The demand for physiotherapy services keeps increasing due to the rising geriatric population and musculoskeletal disorders and injuries thereby providing more opportunities for the Singapore physiotherapy market to grow. The physiotherapy market is segmented by treatment and conditions.
Kenya sleep management market is witnessing significant growth due to factors like busy lifestyles leading to disturbance in sleeping patterns and depression in Kenya. The introduction of home sleep test kits and wearables increases the opportunities for market growth.
The India oncology drugs market is expected to grow from $3.57 Bn in 2022 to 10.62 Bn in 2030 with a CAGR of 14.6% for the year 2022-2030. The rising prevalence of different types of cancers and new drug launches are responsible for this significant growth rate of India oncology drugs market.
UK physiotherapy market is at around $1.38 Bn in 2022 and is expected to grow to $1.87 Bn in 2030 with a CAGR of 3.85% for the year 2022-2030. The increasing geriatric population and high prevalence of musculoskeletal disorders are the major market drivers of UK physiotherapy market. The UK physiotherapy market is segmented by treatment and conditions.
The Egypt Over The Counter (OTC) Market is a rapidly growing industry, driven by factors such as increased access to healthcare, growing awareness of self-care, and a rising middle class with higher disposable incomes. The market is dominated by multinational companies, with a number of local companies also participating in the market.
The Egypt Osteoporosis Market is expected to grow due to the increasing aging population and increasing awareness of osteoporosis. Osteoporosis is a condition characterized by low bone density and increased risk of fractures, which is common in older adults. The market is segmented by drug class and by route of administration.
The Egypt gastrointestinal market is growing due to a number of factors, including increasing prevalence of gastrointestinal diseases, rising awareness about digestive health, and advancements in medical technology. The government has taken steps to improve healthcare infrastructure, including increasing investment in hospitals and clinics, which is driving growth in the gastrointestinal market. The market is dominated by multinational pharmaceutical companies, but there is also a growing number of local players.
The Egypt Dental Care Market is expected to grow as a result of the increasing prevalence of dental disorders and the rising demand for cosmetic dentistry in Egypt. The Egypt dental care market is segmented by products and equipment, services, and the end user. Egypt is expected to offer high-growth opportunities to the players during the forecast period. SHOFU Dental and KaVo Dental are some of the key players in the Egypt dental care market.
Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Australia's digital health market was valued at $2.5 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 20.10% from 2022 to 2030 and will reach $10.96 Bn in 2030. One of the main reasons propelling the growth of this market is rising smartphone adoption, improved internet connectivity, and improved healthcare. The market is segmented by product, by end-user, and by component. Some key players in this market are Alcidion Corp., Doctors on Demand Pty Ltd, Ellume Limited, Genie Solutions Pty Ltd, and Harrison-Al Pty Ltd.
Australia's Dialysis Market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. The incidence of CKD in Australia is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
The Belgium Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.02 Bn in 2022 to $0.3 Bn by 2030, registering a CAGR of 45.22% during the forecast period of 2022 - 2030. The market will be driven by a strong healthcare system, a culture of innovation, and government support for research and development. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, OncoDNA & FibriCheck.